Cargando…

The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation

BACKGROUND: There is no data regarding the association between the platelet-to-lymphocyte ratio (PLR) and long-term mortality in patients with stable coronary artery disease (SCAD). The aim of this study is to evaluate the utility of the pre-procedural PLR for predicting long-term, all-cause mortali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osadnik, Tadeusz, Wasilewski, Jarosław, Lekston, Andrzej, Strzelczyk, Joanna, Kurek, Anna, Gonera, Małgorzata, Gawlita, Marcin, Reguła, Rafał, Bujak, Kamil, Szyguła-Jurkiewicz, Bożena, Wiczkowski, Andrzej, Poloński, Lech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481420/ https://www.ncbi.nlm.nih.gov/pubmed/26136628 http://dx.doi.org/10.1016/j.jsha.2015.02.004

Ejemplares similares

The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease
por: Osadnik, Tadeusz, et al.
Publicado: (2016)

Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center
por: Wasilewski, Jarosław, et al.
Publicado: (2015)

The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Patients with Stable Coronary Artery Disease Treated with Bare Metal Stent
por: Osadnik, Tadeusz, et al.
Publicado: (2016)

The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention
por: Osadnik, Tadeusz, et al.
Publicado: (2017)

Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease
por: Osadnik, Tadeusz, et al.
Publicado: (2013)

High progesterone levels are associated with family history of premature coronary artery disease in young healthy adult men
por: Osadnik, Tadeusz, et al.
Publicado: (2019)

Family History of Premature Coronary Artery Disease (P-CAD)—A Non-Modifiable Risk Factor? Dietary Patterns of Young Healthy Offspring of P-CAD Patients: A Case-Control Study (MAGNETIC Project)
por: Osadnik, Tadeusz, et al.
Publicado: (2018)

The Role of Septal Perforators and “Myocardial Bridging Effect” in Atherosclerotic Plaque Distribution in the Coronary Artery Disease
por: Wasilewski, Jarosław, et al.
Publicado: (2015)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

The obesity paradox in acute coronary syndrome: a meta-analysis
por: Niedziela, Jacek, et al.
Publicado: (2014)

Metabolic and genetic profiling of young adults with and without a family history of premature coronary heart disease (MAGNETIC). Study design and methodology
por: Osadnik, Tadeusz, et al.
Publicado: (2019)

The Prognostic Role of Red Blood Cell Distribution Width in Coronary Artery Disease: A Review of the Pathophysiology
por: Bujak, Kamil, et al.
Publicado: (2015)

Comparison of outcomes in patients undergoing rotational atherectomy after unsuccessful coronary angioplasty versus elective rotational atherectomy
por: Gorol, Jaroslaw, et al.
Publicado: (2018)

Risk factors for paravalvular leak after transcatheter aortic valve implantation
por: Wilczek, Krzysztof, et al.
Publicado: (2015)

Diffuse coronary artery ectasia in a patient with left main coronary artery trifurcation
por: Wasilewski, Jarosław, et al.
Publicado: (2016)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

Metabolically healthy obese and metabolic syndrome of the lean: the importance of diet quality. Analysis of MAGNETIC cohort
por: Osadnik, Kamila, et al.
Publicado: (2020)

Predominant location of coronary artery atherosclerosis in the left anterior descending artery. The impact of septal perforators and the myocardial bridging effect
por: Wasilewski, Jarosław, et al.
Publicado: (2015)

Not at random location of atherosclerotic lesions in thoracic aorta and their prognostic significance in relation to the risk of cardiovascular events
por: Wasilewski, Jarosław, et al.
Publicado: (2013)

CHA(2)DS(2)-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Invasive and non-invasive fractional flow reserve index in validation of hemodynamic severity of intracoronary lesions
por: Wasilewski, Jarosław, et al.
Publicado: (2013)

VDR Gene Polymorphisms in Healthy Individuals with Family History of Premature Coronary Artery Disease
por: Fronczek, Martyna, et al.
Publicado: (2021)

Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Calcific aortic valve damage as a risk factor for cardiovascular events
por: Wasilewski, Jarosław, et al.
Publicado: (2012)

Oxidative damage and carcinogenesis
por: Strzelczyk, Joanna Katarzyna, et al.
Publicado: (2012)

Early and long-term outcomes of complete revascularization with percutaneous coronary intervention in patients with multivessel coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes
por: Hawranek, Michał, et al.
Publicado: (2018)

Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
por: Gąsior, Paweł, et al.
Publicado: (2013)

Long-term outcomes of patients with multivessel coronary artery disease presenting non-ST-segment elevation acute coronary syndromes
por: Desperak, Piotr, et al.
Publicado: (2019)

COVID-19 mimicking ST-elevation myocardial infarction
por: Bujak, Kamil, et al.
Publicado: (2020)

Oxidative Stress Markers in Hypertrophic Cardiomyopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Myocardial Infarction in Centenarians. Data from The Polish Registry of Acute Coronary Syndromes
por: Piegza, Jacek, et al.
Publicado: (2020)

The Effects of Cardiac Rehabilitation including Nordic Walking in Patients with Chronic Coronary Syndromes after Percutaneous Coronary Interventions in Elective Mode
por: Januszek, Rafał, et al.
Publicado: (2023)

Double stent loss during multivessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome
por: Hawranek, Michał, et al.
Publicado: (2014)

Survival rate after acute myocardial infarction in patients treated with percutaneous coronary intervention within the left main coronary artery according to time of admission
por: Januszek, Rafał, et al.
Publicado: (2021)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

Potential use of histone deacetylase inhibitors in cancer therapy
por: Gołąbek, Karolina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v0ik4c075edcq01aaab6tn083n